Publications 2018

Broicher SD, Filli L, Geisseler O, Germann N, Zörner B, Brugger P, Linnebank M. Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years. J Neurol. 2018 May;265(5):1016-1025.

Filli L, Sutter T, Easthope CS, Killeen T, Meyer C, Reuter K, Lörincz L, Bolliger M, Weller M, Curt A, Straumann D, Linnebank M, Zörner B. Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time. Sci Rep. 2018 Mar 21;8(1):4984.

Huber E, David G, Thompson AJ, Weiskopf N, Mohammadi S, Freund P. Dorsal and ventral horn atrophy is associated with clinical outcome after spinal cord injury. Neurology. 2018 Apr 24;90(17):e1510-e1522.

Popp WL, Richner L, Brogioli M, Wilms B, Spengler CM, Curt AEP, Starkey ML, Gassert R. Estimation of Energy Expenditure in Wheelchair-Bound Spinal Cord Injured Individuals Using Inertial Measurement Units.Front Neurol. 2018 Jul 3;9:478. doi: 10.3389/fneur.2018.00478. eCollection 2018.

Wolf K, Hupp M, Friedl S, Sutter R, Klarhöfer M, Grabher P, Freund P, Curt A. In cervical spondylotic myelopathy spinal cord motion is focally increased at the level of stenosis: a controlled cross-sectional study. Spinal Cord. 2018 Mar 1. [Epub ahead of print]
Ziegler G, Grabher P, Thompson A, Altmann D, Hupp M, Ashburner J, Friston K, Weiskopf N, Curt A, Freund P. Progressive neurodegeneration following spinal cord injury: Implications for clinical trials. Neurology. 2018 Apr 3;90(14):e1257-e1266. Epub 2018 Mar 7.